Variant report
Variant | nsv508223 |
---|---|
Chromosome Location | chr3:68603630-68645355 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs72106943 | chr3:68605002-68605003 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs36021206 | chr3:68605051-68605052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs182349293 | chr3:68605057-68605058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs73835307 | chr3:68605061-68605062 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs549386043 | chr3:68605071-68605072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs551269042 | chr3:68605121-68605122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs571060319 | chr3:68605124-68605125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs537295488 | chr3:68605146-68605147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs187789028 | chr3:68605147-68605148 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs576511662 | chr3:68605157-68605158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs369690111 | chr3:68605159-68605160 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs199513256 | chr3:68605264-68605265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs574766521 | chr3:68605305-68605306 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs7647115 | chr3:68605368-68605369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs572483811 | chr3:68605410-68605411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs73835308 | chr3:68605428-68605429 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs192546047 | chr3:68605461-68605462 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs578103580 | chr3:68605492-68605493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs74771752 | chr3:68605508-68605509 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs10576290 | chr3:68605536-68605537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs563214130 | chr3:68605573-68605574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs528952987 | chr3:68605576-68605577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs548681795 | chr3:68605598-68605599 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs35966038 | chr3:68605751-68605752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs35522170 | chr3:68605766-68605767 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs142653330 | chr3:68605796-68605797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs184492924 | chr3:68605797-68605798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs13321458 | chr3:68610030-68610031 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs188345845 | chr3:68610170-68610171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs532539999 | chr3:68610174-68610175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs181822206 | chr3:68610216-68610217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs563234387 | chr3:68610245-68610246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs17246157 | chr3:68610324-68610325 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs548825640 | chr3:68610350-68610351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs568689407 | chr3:68610365-68610366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs185701658 | chr3:68610429-68610430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs1511888 | chr3:68610451-68610452 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs17047842 | chr3:68610525-68610526 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs570351603 | chr3:68610567-68610568 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs530741728 | chr3:68610571-68610572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs34987289 | chr3:68610573-68610574 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs190702106 | chr3:68610598-68610599 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs569963223 | chr3:68610627-68610628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs17047843 | chr3:68610632-68610633 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs17047845 | chr3:68610660-68610661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs186986684 | chr3:68610663-68610664 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs17047847 | chr3:68610677-68610678 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs190087237 | chr3:68610699-68610700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs181422632 | chr3:68610714-68610715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs9835386 | chr3:68610847-68610848 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16608533 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 19490591 | CNVD |
Autism | 18414403 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Metastatic melanoma | 17975146 | CNVD |
Breast cancer | 21509527 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Autism | 22102821 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 21062444 | CNVD |
Prostate cancer | 17217626 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Mental retardation | 20848658 | CNVD |
Breast cancer | 17142309 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:68605000-68605800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
2 | chr3:68610000-68612000 | Enhancers | Fetal Lung | lung |
3 | chr3:68620000-68620600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr3:68620600-68620800 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
5 | chr3:68620800-68622400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
6 | chr3:68622400-68622600 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
7 | chr3:68624400-68625000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
8 | chr3:68624600-68625200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
9 | chr3:68628200-68628400 | ZNF genes & repeats | H1 Derived Mesenchymal Stem Cells | ES cell derived |